Amylyx Pharmaceuticals Inc Capital Reinvestment Ratio
Amylyx Pharmaceuticals Inc capital reinvestment ratio. Amylyx Pharmaceuticals Inc (AMLX) has a Capital Reinvestment Ratio of 0.03x as of December 2023, meaning it reinvests 0% of its operating cash flow ($13.55 Million) in capital expenditures ($356.00K). Check AMLX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Amylyx Pharmaceuticals Inc (2023–2023)
Capital reinvestment ratio of Amylyx Pharmaceuticals Inc from 2023 to 2023. This chart tracks Amylyx Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Amylyx Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
Amylyx Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2023–2023)
Amylyx Pharmaceuticals Inc capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see cash efficiency ratio of Amylyx Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.10x | $11.92 Million | $1.24 Million | — |